A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A multicenter, open-label observational trial assessing the safety and effectiveness of LivaloZet® tablets in individuals with dyslipidemia and metabolic syndrome: Protocol for the PIVOT study

  • By

  • Kyong Hye Joung

  • Bon Jeong Ku

  • July 10, 2026

Share

Original Source(s)

Related Content